Abstract
Targets Patients: Patients with a diagnosis of rheumatoid arthritis according to the criteria of the Brazilian Consensus of Rheumatoid arthritis of the Brazilian Society of Rheumatology, in 18 years, of both sex treated with drugs modifying rheumatoid arthritis immunobiological agents and anti- TNF alpha that have evolved with atherosclerotic cardiovascular disease.Care Context: Patients …